IP Library › Granted Patent US 12,414,761
Granted Patent B2
US 12,414,761 · App. 16/516,112 · Granted Sep 16, 2025

Devices and methods for targeted delivery of a substance

Inventors: John S. Pollack (Naperville, IL); William R. Voss (Hinsdale, IL)
Assignee: Sanulus Medical, LLC
A61B17/00491A61B18/18A61F9/00727A61F9/0079A61B2017/00818A61B17/205A61B2018/00595A61B2018/1807
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,414,761
App. No.
16/516,112
Granted
Sep 16, 2025
Kind
B2
Abstract

A device for applying a bubble of a substance to a tissue surface, the device comprising a cannula, a distal tip at the distal end portion of the cannula, the distal tip having a bubble support surface and an exit port extending through the bubble support surface, an expansion fluid passageway extending through the cannula to the exit port, a source of an expansion fluid and an actuator therefor. In some arrangements, the distal tip can be configured to support a layer of the substance thereon over the distal port and the device can be configured such that the advancement of the expansion fluid from the fluid source through the exit port causes at least one bubble of the substance to form on the distal tip, wherein the at least a portion of the bubble can be transferred to the tissue surface to treat a defect on the tissue surface.

Claims (71)

1. A device for applying a bubble of a bioadhesive substance to a tissue surface of an eye, the device comprising:

a cannula comprising a proximal end portion, a distal end portion, and an intermediate portion extending therebetween;

a distal tip at the distal end portion of the cannula configured for insertion into the eye, the distal tip having an outer, longitudinally extending surface, the distal tip having a wall with an inner surface defining a lumen of a first diameter for passage of an expansion gas, the wall having a thickness between the distal tip outer surface and the wall inner surface, the distal tip defining an exit port in fluid communication with the lumen, the exit port having a diameter that is smaller than the lumen first diameter, the exit port circumvented by a rim that extends from the distal tip outer surface inward relative to the wall inner surface, the rim having a flat, circumferential face forming a distal most surface of the distal tip, an entirety of the circumferential face being flat, the flat, circumferential face having a width between an outer diameter and an inner diameter of the flat, circumferential face that is larger than the wall thickness, the rim configured to support a layer of the bioadhesive substance on the flat, circumferential face;

a bioadhesive pathway for introducing the bioadhesive substance to the flat, circumferential face of the rim;

an expansion gas passageway extending through at least the intermediate portion and the distal end portion of the cannula, the expansion gas passageway being in fluid communication with the distal tip lumen and being configured to provide a passageway for the expansion gas separate from the bioadhesive pathway along a length of the intermediate and distal end portions of the cannula all the way to the exit port, the expansion gas passageway being coaxial with the bioadhesive pathway; and

an actuator configured to couple with a source of the expansion gas and configured to selectively advance the expansion gas through the expansion gas passageway and the distal tip lumen upon actuation of the actuator and to direct the expansion gas to the layer of the bioadhesive substance to form the bubble of the bioadhesive substance on the flat, circumferential face of the rim with the layer of the bioadhesive substance at least partially surrounding a volume of the expansion gas.

2. The device of claim 1 , comprising a handle portion at a proximal end of the device, the handle portion configured to support at least the actuator and the source of expansion gas.

3. The device of claim 1 , wherein the device is configured to form a bubble that comprises a spherically shaped film of the bioadhesive substance at least partially enclosing the expansion gas.

4. The device of claim 1 , wherein the actuator comprises a compressible bladder configured to expel the expansion gas from the source of the expansion gas within the bladder through the expansion gas passageway.

5. The device of claim 1 , wherein the actuator comprises a wheel moveable along a compressible bladder configured to expel the expansion gas from the source of the expansion gas within the bladder through the expansion gas passageway.

6. The device of claim 1 , wherein the bioadhesive pathway surrounds the expansion gas passageway.

7. The device of claim 1 , wherein the bioadhesive pathway comprises an elongate body comprising a proximal end and a distal end having a distal tip with at least one opening therein, the elongate body being advanceable through the expansion gas passageway to the distal tip at the distal end portion of the cannula.

8. The device of claim 1 , wherein the bioadhesive pathway is internal to or surrounded by at least a portion of the expansion gas passageway of the cannula.

9. The device of claim 1 , further comprising a cautery component configured to increase the temperature of at least the distal tip of the device.

10. The device of claim 1 , wherein the flat, circumferential face of the rim is not beveled perpendicular to a longitudinal extent of the cannula.

11. The device of claim 1 , wherein the flat, circumferential face of the rim is beveled.

12. The device of claim 1 , wherein the width of the flat, circumferential face is in the range of 0.1 mm to 0.5 mm.

13. The device of claim 1 , wherein the width of the flat, circumferential face is in the range of 0.5 mm to 1 mm.

14. The device of claim 1 , wherein the distal tip defines a single exit port.

15. The device of claim 1 , further comprising a manifold surrounding the exit port, the bioadhesive pathway being in fluid communication with the manifold.

16. The device of claim 1 , wherein the distal tip comprises a hydrophobic material.

17. The device of claim 1 , wherein the rim is configured to support the layer of the bioadhesive substance on an entirety of the flat, circumferential face.

18. A handheld device for applying a bioadhesive bubble to a retina of an eye, comprising:

an elongate body comprising a first end and a second end, the first end comprising a handle, the second end comprising a cannula configured for insertion into the eye and having a wall with an outer, longitudinally extending surface, the cannula defining a lumen and having an exit port and a rim having a flat face at a distal most surface of the cannula, an entirety of the rim face being flat, the exit port having a smaller diameter than the lumen and the flat face extending inward from the outer surface into the lumen a distance greater than a thickness of the cannula wall adjacent the flat face;

a bioadhesive reservoir configured for containing a liquid bioadhesive;

a first passageway in communication with the exit port and configured to selectively communicate a supply of an expansion gas through the exit port; and

a second passageway in communication with the bioadhesive reservoir and configured to selectively communicate a supply of the bioadhesive from the bioadhesive reservoir to the second end of the elongate body, wherein the second passageway completely surrounds the first passageway at least at a distal end of the cannula all the way to the exit port;

wherein:

the first passageway is configured to direct the supply of the expansion gas through a layer of the bioadhesive that is received on the flat face to produce the bioadhesive bubble;

the first passageway is configured to maintain the supply of the expansion gas out of contact with the bioadhesive until the expansion gas is directed through the bioadhesive at the flat face;

the flat face is configured to maintain the bioadhesive bubble on the second end when the expansion gas stops flowing through the exit port; and

the second end is configured to release the bioadhesive bubble when the bioadhesive bubble is brushed against a retina or when the expansion gas flows again through the exit port.

19. The handheld device of claim 18 , wherein the elongate body further comprises a joining portion, the joining portion comprising a coupling end configured to interact with a proximal portion of the cannula, and wherein the proximal portion of the cannula is configured to reversibly interact with the coupling end of the elongate body.

20. The device of claim 18 , wherein the flat face has a width in the range of 0.1 mm to 0.5 mm.

21. The device of claim 18 , wherein the flat face has a width in the range of 0.5 mm to 1 mm.

22. The device of claim 18 , wherein the distal tip defines a single exit port.

23. The device of claim 18 , further comprising a manifold surrounding the exit port, the bioadhesive pathway being in fluid communication with the manifold.

24. The device of claim 18 , wherein the distal tip comprises a hydrophobic material.

25. A device for applying a bubble of a bioadhesive substance to a tissue surface, the device comprising:

a cannula comprising a proximal end portion, a distal end portion, and an intermediate portion extending therebetween along a longitudinal axis;

a distal tip at the distal end portion of the cannula, the distal tip having an outer longitudinally extending surface, the distal tip having a wall of a first thickness defining a lumen of a first diameter for passage of an expansion gas, the distal tip defining only a single exit port, the exit port having a smaller diameter than the lumen first diameter, the exit port circumvented by a rim of larger dimension than the first thickness, the rim having a circumferential face extending inward from the distal tip outer surface, the circumferential face oriented at an acute angle to the longitudinal axis along an entirety of the circumferential face, the rim configured to support a layer of the bioadhesive substance on the circumferential face;

a bioadhesive pathway for introducing the bioadhesive substance to the circumferential face of the rim;

an expansion gas passageway extending through at least the intermediate portion and the distal end portion of the cannula, the expansion gas passageway being in fluid communication with the distal tip lumen and being configured to provide a passageway for the expansion gas separate from the bioadhesive pathway along a length of the intermediate and distal end portions of the cannula, the expansion gas passageway and bioadhesive pathway remaining separate all the way to the exit port; and

an actuator configured to couple with a source of the expansion gas and configured to selectively advance the expansion gas through the expansion gas passageway and the distal tip lumen upon actuation of the actuator and to direct the expansion gas to the layer of the bioadhesive substance to form the bubble of the bioadhesive substance on the circumferential face of the rim with the layer of the bioadhesive substance at least partially surrounding a volume of the expansion gas.

26. The device of claim 25 , wherein the circumferential face has a width in the range of 0.1 mm to 0.5 mm.

27. The device of claim 25 , wherein the circumferential face has a width in the range of 0.5 mm to 1 mm.

28. The device of claim 1 , further comprising a manifold surrounding the exit port, the bioadhesive pathway being in fluid communication with the manifold.

29. The device of claim 25 , wherein the distal tip comprises a hydrophobic material.

30. The device of claim 25 , wherein the distal tip is configured for insertion into the eye.

31. The device of claim 25 , wherein the rim is configured to support a layer of the bioadhesive substance on the entirety of the circumferential face.

32. The device of claim 25 , wherein an entirety of the circumferential face is flat.

33. A device for applying a bubble of a bioadhesive substance to a tissue surface, the device comprising:

a cannula comprising a proximal end portion, a distal end portion, and an intermediate portion extending therebetween along a longitudinal axis;

a distal tip at the distal end portion of the cannula, the distal tip having a wall of a first thickness defining a lumen of a first diameter, the distal tip defining an exit port in fluid communication with the lumen, the exit port having a smaller diameter than the lumen first diameter, and a deflector extending into the lumen and having a distal facing surface located within the distal tip;

a bioadhesive pathway for introducing the bioadhesive substance to the distal facing surface of the deflector;

an expansion gas passageway defined by a member extending through at least the intermediate portion and the distal end portion of the cannula, the expansion gas passageway being in fluid communication with the lumen and being configured to provide a passageway for the expansion gas separate from the bioadhesive pathway along a length of the intermediate and distal end portions of the cannula, the deflector configured to direct flow of the bioadhesive substance radially inwardly about a distal end of the member defining the passageway for the expansion gas, the distal end of the member spaced proximal of the deflector; and

an actuator configured to couple with a source of the expansion gas and configured to selectively advance the expansion gas through the expansion gas passageway and the lumen upon actuation of the actuator and to direct the expansion gas to a layer of the bioadhesive substance to form the bubble of the bioadhesive substance on the distal facing surface of the deflector with the layer of the bioadhesive substance at least partially surrounding a volume of the expansion gas.

34. The device of claim 33 , wherein the distal tip is configured for insertion into the eye.

35. A device for applying a bubble of a bioadhesive substance to a tissue surface of an eye, the device comprising:

a cannula comprising a proximal end portion, a distal end portion, and an intermediate portion extending therebetween;

a distal tip at the distal end portion of the cannula configured for insertion into the eye, the distal tip having an outer, longitudinally extending surface, the distal tip having a wall with an inner surface defining a lumen of a first diameter for passage of an expansion gas, the wall having a thickness between the distal tip outer surface and the wall inner surface, the distal tip defining an exit port in fluid communication with the lumen, the exit port having a diameter that is smaller than the lumen first diameter, the exit port circumvented by a rim that extends from the distal tip outer surface inward relative to the wall inner surface, the rim having a flat, circumferential face forming a distal most surface of the distal tip, an entirety of the circumferential face being flat, the flat, circumferential face having a width between an outer diameter and an inner diameter of the flat, circumferential face that is larger than the wall thickness, the rim configured to support a layer of the bioadhesive substance on the flat, circumferential face;

a bioadhesive pathway for introducing the bioadhesive substance to the flat, circumferential face of the rim;

an expansion gas passageway having a central axis extending through at least the intermediate portion and the distal end portion of the cannula, the expansion gas passageway being in fluid communication with the distal tip lumen and being configured to provide a passageway for the expansion gas separate from the bioadhesive pathway along a length of the intermediate and distal end portions of the cannula all the way to the exit port, the central axis of the expansion gas pathway being aligned with a center of the exit port; and

an actuator configured to couple with a source of the expansion gas and configured to selectively advance the expansion gas through the expansion gas passageway and the distal tip lumen upon actuation of the actuator and to direct the expansion gas to the layer of the bioadhesive substance to form the bubble of the bioadhesive substance on the flat, circumferential face of the rim with the layer of the bioadhesive substance at least partially surrounding a volume of the expansion gas.

36. The device of claim 35 , wherein the flat face has a width in the range of 0.1 mm to 0.5 mm.

37. The device of claim 35 , wherein the flat face has a width in the range of 0.5 mm to 1 mm.

38. The device of claim 35 , wherein the distal tip defines a single exit port.

39. The device of claim 38 , wherein the distal tip defines only the single exit port.

40. The device of claim 35 , further comprising a manifold surrounding the exit port, the bioadhesive pathway being in fluid communication with the manifold.

41. The device of claim 35 , wherein the distal tip comprises a hydrophobic material.

42. The device of claim 35 , wherein the rim is configured to support the layer of the bioadhesive substance on an entirety of the flat, circumferential face.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 30, 2019
From: POLLACK, JOHN S.; VOSS, WILLIAM R.
To: SANULUS MEDICAL, LLC
Reel/Frame 050227/0164 →
Continuity (3)
Provisional Application 62796338 · Jan 24, 2019
Provisional Application 62700768 · Jul 19, 2018
Related Publication 20200022691A1 · Jan 23, 2020
References Cited (125)
US 2599888A · Beezlet et al. · 1952 [cited by applicant]
US 2828579A · Schwerbel et al. · 1958 [cited by applicant]
US 3834066A · Vargas · 1974 [cited by applicant]
US 4752383A · McKay · 1988 [cited by examiner]
US 4762004A · Lalin et al. · 1988 [cited by applicant]
US 4795436A · Robinson · 1989 [cited by applicant]
US 4874368A · Miller et al. · 1989 [cited by applicant]
US 4907961A · Anderson · 1990 [cited by examiner]
US 5019037A · Wang et al. · 1991 [cited by applicant]
US 5324305A · Kanner · 1994 [cited by examiner]
US 5334163A · Sinnett · 1994 [cited by examiner]
US 5368563A · Lonneman · 1994 [cited by examiner]
US 5527356A · Peyman et al. · 1996 [cited by applicant]
US 5547473A · Peyman · 1996 [cited by applicant]
US 5844087A · Zimmerman et al. · 1998 [cited by applicant]
US 5858345A · Charles et al. · 1999 [cited by applicant]
US 6296150B1 · Farris · 2001 [cited by examiner]
US 6328229B1 · Duronio · 2001 [cited by examiner]
US 6475508B1 · Schwartz et al. · 2002 [cited by applicant]
US 6478775B1 · Galt · 2002 [cited by examiner]
US 6488695B1 · Hickingbotham · 2002 [cited by applicant]
US 6547467B2 · Quintero · 2003 [cited by examiner]
US 6589269B2 · Zhu et al. · 2003 [cited by applicant]
US 7044937B1 · Kirwan · 2006 [cited by examiner]
US 7220224B1 · Peyman · 2007 [cited by applicant]
US 7338477B2 · Meyer et al. · 2008 [cited by applicant]
US 7867222B1 · Tilton, Jr. et al. · 2011 [cited by applicant]
US 7985197B2 · Maeda et al. · 2011 [cited by applicant]
US 8323262B2 · D'Alessio et al. · 2012 [cited by applicant]
US 8470029B2 · Walter et al. · 2013 [cited by applicant]
US 8790366B2 · Cordova · 2014 [cited by applicant]
US 8950629B2 · Kapec et al. · 2015 [cited by applicant]
US 9186315B2 · Singer · 2015 [cited by examiner]
US 9554939B1 · Breazeale · 2017 [cited by applicant]
US 9623144B2 · Askari et al. · 2017 [cited by applicant]
US 9694299B1 · Kouso · 2017 [cited by applicant]
US 9861942B1 · Paul et al. · 2018 [cited by applicant]
US 9937300B2 · Beckstein et al. · 2018 [cited by applicant]
US 10052350B2 · Niu et al. · 2018 [cited by applicant]
US 10500090B2 · Gunn et al. · 2019 [cited by applicant]
US 11166844B2 · Charles et al. · 2021 [cited by applicant]
US 20010016709A1 · Tovey · 2001 [cited by examiner]
US 20030044219A1 · Quintero · 2003 [cited by applicant]
US 20030225380A1 · Redl · 2003 [cited by examiner]
US 20040039253A1 · Peyman · 2004 [cited by examiner]
US 20060151531A1 · Tikusis · 2006 [cited by examiner]
US 20070092550A1 · Lui · 2007 [cited by applicant]
US 20070191781A1 · Richards · 2007 [cited by examiner]
US 20070208422A1 · Walter et al. · 2007 [cited by applicant]
US 20080121657A1 · Voegele · 2008 [cited by examiner]
US 20080294093A1 · Maeda et al. · 2008 [cited by applicant]
US 20100114158A1 · Hattan · 2010 [cited by examiner]
US 20100168779A1 · Redl · 2010 [cited by examiner]
US 20100228122A1 · Keenan · 2010 [cited by examiner]
US 20100261652A1 · Wang et al. · 2010 [cited by applicant]
US 20120035335A1 · Ladet · 2012 [cited by examiner]
US 20120271272A1 · Hammack et al. · 2012 [cited by applicant]
US 20130022590A1 · MacKay et al. · 2013 [cited by applicant]
US 20130190808A1 · Tegels et al. · 2013 [cited by applicant]
US 20130261538A1 · Miyazaki · 2013 [cited by examiner]
US 20140206940A1 · Hufford · 2014 [cited by examiner]
US 20140330204A1 · Huculak et al. · 2014 [cited by applicant]
US 20150165181A1 · Honda et al. · 2015 [cited by applicant]
US 20150283364A1 · Tanaka et al. · 2015 [cited by applicant]
US 20160220725A1 · Whalen, III et al. · 2016 [cited by applicant]
US 20160271290A1 · Humayun et al. · 2016 [cited by applicant]
US 20170100128A1 · Soens et al. · 2017 [cited by applicant]
US 20170165109A1 · Gunn et al. · 2017 [cited by applicant]
US 20170172793A1 · Gunn et al. · 2017 [cited by applicant]
US 20170333253A1 · Heeren et al. · 2017 [cited by applicant]
US 20180036452A1 · Askari et al. · 2018 [cited by applicant]
US 20180360743A1 · Bartynski et al. · 2018 [cited by applicant]
US 20190254705A1 · Humayun · 2019 [cited by applicant]
US 20200375844A1 · Maschio et al. · 2020 [cited by applicant]
US 20210121326A1 · Kahook et al. · 2021 [cited by applicant]
US 20220008250A1 · Pollack et al. · 2022 [cited by applicant]
FR 2505150 · 1982 [cited by applicant]
JP 2007527256A · 2007 [cited by applicant]
JP 2009000511A · 2009 [cited by applicant]
JP 4569971 · 2010 [cited by applicant]
JP 2015530202 · 2015 [cited by applicant]
WO WO2004110282A1 · 2004 [cited by applicant]
WO WO2011061297A1 · 2011 [cited by applicant]
WO WO2012149468 · 2012 [cited by applicant]
WO WO2014056895 · 2014 [cited by applicant]
WO WO2017060913 · 2017 [cited by applicant]
WO WO2017103818A1 · 2017 [cited by applicant]
WO WO2018232384 · 2018 [cited by applicant]
International Search Report and Written Opinion in PCT/US2019/042481; dated Nov. 12, 2019; 17 pages. [cited by applicant]
How to Cut a Straw for Blowing Bubbles: Custom Crafts, as available at https://www.youtube.com/watch?v=0PIsUM_QILQ on Dec. 20, 2019; 5 pages. [cited by applicant]
Sani, et al., “Sutureless repair of corneal injuries using naturally derived bioadhesive hydorgels,” Science Advances, Mar. 20, 2019; 14 pages. [cited by applicant]
Brownell, Lindsay, “Sticky when hot: strong adhesive for wound healing,” Jun. 27, 2017; 10 pages. [cited by applicant]
PCT International Preliminary Report on Patentability in International Appln. No. PCT/US2019/042481, dated Feb. 1, 2021, 9 pages. [cited by applicant]
Alcon, “The Advanced ULTRAVIT Beveled High Speed Probe,” NRMD, 2017, 2, 1 page. [cited by applicant]
Annabi et al., “Engineering a high elastic human protein-based sealant for surgical applications,” Sci, Transl. Med., Oct. 2017, 9, 12 pages. [cited by applicant]
Barliya et al., “Transcleral approach for closing retinal tears using DuraSeal™ hydrogel sealant,” Feb. 2018, 66(2):238-243. [cited by applicant]
Bayat et al., “A reversible thermoresponsive sealant for temporary closure of ocular trauma,” Science Translational Medicine, Dec. 2017, 9(419), 47 pages. [cited by applicant]
Brownell, “Sticky when wet: strong adhesive for wound healing,” Wyss Institute, Jul. 27, 2017, 10 pages. [cited by applicant]
Gilbert, “Adhesives in retinal detachment surgery,” Br. J. Ophthalmol., 1991, 75:309- 310. [cited by applicant]
Hofman et al., “Bioinspired Underwater Adhesives by Using the Supramolecular Toolbox,” Adv. Mater., 2018, 30(19):1-38. [cited by applicant]
International Search Report and Written Opinion in International Appln. No. PCT/US20201/070831, dated Oct. 27, 2021, 15 pages. [cited by applicant]
Khalil et al., “Ciprofloxacin-loaded Bioadhesive Hydrogels for Ocular Applications,” Biomaterials Science, 2020, 16 pages. [cited by applicant]
Kolasinski, “Bubbles: A review of their relationship to the formation of thin films and porous material,” Mesoporous Biomaterials, 2014:49-60. [cited by applicant]
MedOne.com [online], “DualBore Cannulas,” Available 2016, retrieved from URL<https://medone.com/dual-bore-cannulas/>, 2 pages. [cited by applicant]
North et al., “High Strength Underwater Bonding with Polymer Mimics of Mussel Adhesive Proteins,” ACS, Feb. 2017, 7866-7872. [cited by applicant]
Perdue.edu [online], “New ‘biomimetic’ glue shows high-strength bonding under water,” Mar. 2017, retrieved on Apr. 29, 2022, retrieved from URL <https://www.purdue.edu/newsroom/releases/2017/Q1/new-biomimetic-glue-shows… [cited by applicant]
Sani et al., “Sutureless repair of corneal injuries using naturally derived bioadhesive hydorgels,” Sci. Adv., Mar. 20, 2019, 5:1-14. [cited by applicant]
Sarfare et al., “Biocompatibility of a Synthetic Biopolymer for the treatment of Rhegmatogenous Retinal Detachment,” J Clin Exp Ophthalmol., 2015 6(5):1-8. [cited by applicant]
Sciencedaily.com [online], “New insights into underwater adhesives,” Jan. 16, 2018, retrieved on Apr. 29, 2022, retrieved from URL <https://www.sciencedaily.com/releases/2018/01/180116123801.htm>, 4 pages. [cited by applicant]
Teruya et al., “Patching retinal breaks with Seprafilm in experimental rhegmatogenous retinal detachment of rabbit eyes,” Eye, Jan. 2009, 2256-2259. [cited by applicant]
Trikha et al., “Small Gauge Pars Plana Vitrectomy,” Vitrectomy, Apr. 2012, Chapter 4, p. 63. [cited by applicant]
Tyagi et al., “Glue-assisted retinopexy for rhegmatogenous retinal detachments (GuARD): A novel surgical technique for closing retinal breaks,” Indian J. Ophthamol., May 2019, 67(5):677-680. [cited by applicant]
Wang et al., “Intraocular Application of Fibrin Glue as an Adjunct to Pars Plana Vitrectomy for Rhegmatogenous Retinal Detachment,” Retina, the Journal of Retinal and Vitreous Diseases, 2019, 1-7. [cited by applicant]
Wang et al., “Intraocular Application of Fibrin Glue as an Adjunct to Pars Plana Vitrectomy for Rhegmatogenous Retinal Detachment,” Retina, the Journal of Retinal and Vitreous Diseases, 2020, 40(4):718-724. [cited by applicant]
Mamor, “Control of Subretinal Fluid: Experimental and Clinical Studies,” Eye, 1990, 4: 340-344. [cited by applicant]
Tamiya et al.,“Role of epithelial—mesenchymal transition in proliferative vitreoretinopathy,” Experimental Eye Research, 2016, 142: 26-31. [cited by applicant]
International Preliminary Report on Patentability in International Application No. PCT/US2021/070831, mailed on Jan. 19, 2023, 9 pages. [cited by applicant]
Office Action in Japanese Application No. 2021-526400, dated Apr. 4, 2023, 10 pages (with English Translation). [cited by applicant]
European Extended Search Report in European Application No. EP 23157070.6, dated Jul. 4, 2023, 7 pages. [cited by applicant]
Machine Translation of JP4569971, Espacenet, 12 pages. [cited by applicant]
Machine Translation of JP4569971, Japanese Platform for Patent Information, 29 pages. [cited by applicant]
International Search Report and Written Opinion in International Application No. PCT/US2023/070121, mailed on Oct. 31, 2023, 15 pages. [cited by applicant]
Office Action in Japanese Application No. 2021-526400, dated Oct. 3, 2023, 4 pages (with English Translation). [cited by applicant]
Katzin, “Aqueous Fibrin Fixation of Corneal Transplants in the Rabbit,” Archives of Ophthalmology, Apr. 1946, 35(4):415-420. [cited by applicant]
Office Action in Japanese Application No. 2023-501166, dated Dec. 12, 2023, 7 pages (with English Translation). [cited by applicant]